mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |